Sanofi

Latest articles

15h
Channel NewsAsia
China biotech's 'coming out party' masks long road aheadon immuno-oncology, though for now its pipeline is dominated by molecules bough
Channel NewsAsia / Posted 15 hours ago
on immuno-oncology, though for now its pipeline is dominated by molecules bought in from the likes of GlaxoSmithKline, Sanofi and Tesaro. Du hopes to change that one day but says it won't happen overnight. "It's such a long cycle, if you want... Read more
15h
Reuters
China biotech's 'coming out party' masks long road aheadon immuno-oncology, though for now its pipeline is dominated by molecules bough
Reuters / Posted 15 hours ago
on immuno-oncology, though for now its pipeline is dominated by molecules bought in from the likes of GlaxoSmithKline, Sanofi and Tesaro. Du hopes to change that one day but says it won’t happen overnight. “It’s such a long cycle, if you want... Read more
2d
Lowell Sun
Mass. bio-pharma jobs, investments rose substantially in 2016wages, for an average salary of $138,768, according to the report. This year, t
Lowell Sun / Posted 2 days ago
wages, for an average salary of $138,768, according to the report. This year, the state's largest biopharma employer is Sanofi Genzyme, which has 5,000 employees, followed by Shire with 3,040 and Biogen with 2,443. Venture investment in... Read more
2d
EuroNews
Regeneron-Sanofi drug succeeds mid-stage study(Reuters) – Regeneron Pharmaceuticals Inc and Sanofi SA said
EuroNews / Posted 2 days ago
(Reuters) – Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the oesophagus, mainly caused by food allergies, met the main goal of a mid-stage study. The drug, dupilumab, was... Read more
2d
AllAfrica.com
Sanofi Moves to Rescue 5m Nigerians From Diabetesend, a National Diabetes Summit to improve management of the chronic disease an
AllAfrica.com / Posted 2 days ago
end, a National Diabetes Summit to improve management of the chronic disease and patient outcome is being put together by Sanofi Aventis Nigeria Limited in Lagos. At a press conference to herald the maiden edition of the Summit, the Medical... Read more
2d
AllAfrica.com
5 Million Nigerians Are Diabetic, Expert Saysdiagnosed of diabetes, while about 50 per cent of cases are still undiagnosed i
AllAfrica.com / Posted 2 days ago
diagnosed of diabetes, while about 50 per cent of cases are still undiagnosed in the country, the Medical Director, Sanofi Aventis Nigeria Limited, Dr. Philip Ekeme, has revealed. He said the number of persons affected by the silent killer... Read more
3d
Channel NewsAsia
Regeneron-Sanofi throat infection drug succeeds key studyREUTERS: Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug
Channel NewsAsia / Posted 3 days ago
REUTERS: Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat patients with a rare throat infection met the main goal of a mid-stage study. The drug, dupilumab, was statistically significant in improving the ability to... Read more
3d
Boston Globe
Cambridge biotech signs deal to take on ‘superbugs’Drive and a pharmaceutical giant. The company was founded in 2012 in partnershi
Boston Globe / Posted 3 days ago
Drive and a pharmaceutical giant. The company was founded in 2012 in partnership with the French multinational drug company Sanofi and with financing from the venture capital firms Third Rock Ventures and Greylock Partners. Warp Drive, which is also... Read more
3d
Business Wire
Warp Drive Bio Forms Strategic Collaboration to Advance Novel Classes of Antibiotics to Combat Multi-Drug-Resistant Bacterial Infectionsto make a significant difference in patients’ lives. The company was launched i
Business Wire / Posted 3 days ago
to make a significant difference in patients’ lives. The company was launched in 2012 through a strategic partnership with Sanofi and with financing from Third Rock Ventures and Greylock Partners. For more information, please visit... Read more
4d
AllAfrica.com
Nigeria Has Highest Burden of Diabetes in Sub-Saharan Africanliving with the condition, and about 50 percent of the cases still undetected.
AllAfrica.com / Posted 4 days ago
living with the condition, and about 50 percent of the cases still undetected. This was disclosed by the Medical Director, Sanofi Nigeria-Ghana, Dr. Philip Ikeme, during a pre-press briefing ahead of diabetes summit coming up on October 18 in... Read more
6d
dna
24 young adults suffering from Type 1 diabetes scale state's highest peaksuffering from Type 1 diabetes. To show that the children can live normal live
dna / Posted 6 days ago
suffering from Type 1 diabetes. To show that the children can live normal lives, the NGO, along with Diabetes India, and Sanofi India organised a three-day trek to Kalsubai Peak, the highest peak in Maharashtra, located near Igatpuri. "Some of... Read more
6d
FOX Business
A New FDA Approval Sends Small Cap Flexion Soaringtime is, last time they hit a market cap this big, or even particularly close t
FOX Business / Posted 6 days ago
time is, last time they hit a market cap this big, or even particularly close to this big, there was a lot of talk about Sanofi (NYSE: SNY) buying them out. Now, of course, your question is probably, why would Sanofi want to buy them out? Well,... Read more
6d
FOX Business
A New FDA Approval Sends Small Cap Flexion Soaringtime is, last time they hit a market cap this big, or even particularly close t
FOX Business / Posted 6 days ago
time is, last time they hit a market cap this big, or even particularly close to this big, there was a lot of talk about Sanofi (NYSE: SNY) buying them out. Now, of course, your question is probably, why would Sanofi want to buy them out? Well,... Read more
6d
Business Wire
Postgraduate Institute for Medicine, in collaborazione con RMEI Medical Education, annuncia una campagna di sensibilizzazione alla formazione per la Giornata mondiale dell'artrite reumatoideil sostegno di un finanziamento indipendente alla formazione proveniente da Gen
Business Wire / Posted 6 days ago
il sostegno di un finanziamento indipendente alla formazione proveniente da Genzyme, una società del gruppo Sanofi, e da Regeneron Pharmaceuticals, questa iniziativa avanzata, basata sull'analisi dei dati è la prima nel suo genere... Read more
23 related articles
6d
Business Wire
Postgraduate Institute for Medicine, in partnerschap met RMEI Medical Education, kondigt een bewustmakingscampagne voor Wereldartritisdag aanspecialiteiten en disciplines. Ondersteund door onafhankelijke onderwijssubsid
Business Wire / Posted 6 days ago
specialiteiten en disciplines. Ondersteund door onafhankelijke onderwijssubsidiefondsen van Genzyme, een bedrijf van Sanofi, en Regeneron Pharmaceuticals, is dit geavanceerde, door analyse gedreven initiatief de eerste in zijn soort op het... Read more
15 related articles
7d
Business Wire
Postgraduate Institute for Medicine, en partenariat avec RMEI Medical Education, annonce le lancement d'une campagne d'information et de sensibilisation à l'occasion de la Journée mondiale de l'arthriteles différentes spécialités et disciplines. Financée par une subvention indépe
Business Wire / Posted 7 days ago
les différentes spécialités et disciplines. Financée par une subvention indépendante de Genzyme, une société du groupe Sanofi, et Regeneron Pharmaceuticals, cette initiative avancée, basée sur l'analyse, est inédite dans le domaine de... Read more
284 related articles
8d
Boston Globe
Alnylam poised to roll out first-of-its-kind RNA therapy, with a lot riding on the drugbillion in worldwide sales at its peak, which is expected in 2023. The drug, wh
Boston Globe / Posted 8 days ago
billion in worldwide sales at its peak, which is expected in 2023. The drug, which is being developed in conjunction with Sanofi, should be up for review by the Food and Drug Administration in a couple months, and will be up for European... Read more
9d
Business Wire
Foundation Medicine Appoints Tom Civik as Chief Commercial Officera vice president and officer for Genentech, as well as previously serving in in
Business Wire / Posted 9 days ago
a vice president and officer for Genentech, as well as previously serving in increasingly complex commercial positions at Sanofi~Synthelabo. In his new role at Foundation Medicine, Mr. Civik will be responsible for establishing commercial and... Read more
9d
Business Standard India
Pfizer may sell or spin off its $15-billion consumer healthcare businesssecond person familiar with the matter said Pfizer expected a "broadening" of b
Business Standard India / Posted 9 days ago
second person familiar with the matter said Pfizer expected a "broadening" of buyer interest to include Nestle. Bayer and Sanofi may be less likely to bid, despite their consumer health presence, given they are busy absorbing Monsanto and... Read more
39 related articles
9d
Reuters
Pfizer weighs $15 billion sale of consumer healthcare businesssecond person familiar with the matter said Pfizer expected a “broadening” of b
Reuters / Posted 9 days ago
second person familiar with the matter said Pfizer expected a “broadening” of buyer interest to include Nestle. Bayer and Sanofi may be less likely to bid, despite their consumer health presence, given they are busy absorbing Monsanto and... Read more
39 related articles
9d
FOX Business
Pfizer weighs sale of consumer healthcare businessfood and healthcare. One person familiar with the matter said Pfizer expected a
FOX Business / Posted 9 days ago
food and healthcare. One person familiar with the matter said Pfizer expected a "broadening" of buyer interest. Bayer and Sanofi may be less likely to bid, despite their consumer health presence, given they are busy absorbing Monsanto and... Read more
39 related articles
9d
FOX Business
Pfizer weighs sale of consumer healthcare businessfood and healthcare. One person familiar with the matter said Pfizer expected a
FOX Business / Posted 9 days ago
food and healthcare. One person familiar with the matter said Pfizer expected a "broadening" of buyer interest. Bayer and Sanofi may be less likely to bid, despite their consumer health presence, given they are busy absorbing Monsanto and... Read more
39 related articles
9d
Business Wire
Evotec Achieves First Milestone in Neurodegeneration Alliance with Celgenestages (EVT Innovate). Evotec has established multiple long-term discovery alli
Business Wire / Posted 9 days ago
stages (EVT Innovate). Evotec has established multiple long-term discovery alliances with partners including Bayer, CHDI, Sanofi or UCB and development partnerships with e.g. with Sanofi in the field of diabetes, with Pfizer in the field of tissue... Read more
9d
Business Wire
EVOTEC ERREICHT ERSTEN MEILENSTEIN IN CELGENE-ALLIANZ IM BEREICH NEURODEGENERATIVE ERKRANKUNGENaufgebaut (EVT Innovate). Evotec arbeitet in langjährigen Forschungsallianzen m
Business Wire / Posted 9 days ago
aufgebaut (EVT Innovate). Evotec arbeitet in langjährigen Forschungsallianzen mit Partnern wie Bayer, CHDI, Sanofi oder UCB zusammen. Darüber hinaus verfügt das Unternehmen über Entwicklungspartnerschaften u. a. mit Sanofi im Bereich... Read more
565 related articles
11d
FOX Business
News Flash: The FDA Just Approved a Breakthrough Diabetes Deviceas well the kidneys (SGLT-2), possibly improving upon what SGLT-2 inhibitors br
FOX Business / Posted 11 days ago
as well the kidneys (SGLT-2), possibly improving upon what SGLT-2 inhibitors bring to the table. With licensing partner Sanofi running late-stage studies involving sotagliflozin for type 2 diabetics, and Lexicon already reporting positive... Read more
11d
FOX Business
News Flash: The FDA Just Approved a Breakthrough Diabetes Deviceas well the kidneys (SGLT-2), possibly improving upon what SGLT-2 inhibitors br
FOX Business / Posted 11 days ago
as well the kidneys (SGLT-2), possibly improving upon what SGLT-2 inhibitors bring to the table. With licensing partner Sanofi running late-stage studies involving sotagliflozin for type 2 diabetics, and Lexicon already reporting positive... Read more
13d
Business Wire
Women Building Bio Highlighted STEM Achievements, Research Initiatives and Next Generation Inspiration for the Regional Life Sciences CommunityCapital, Biotechnology Innovation Organization, Pfizer, AstraZeneca/MedImmune,
Business Wire / Posted 13 days ago
Capital, Biotechnology Innovation Organization, Pfizer, AstraZeneca/MedImmune, College of William & Mary, Vibrent, Virginia Tech, HHMI Janelia Research Campus, LifeNet Health, Prince William County, Sanofi, Merck and Silverline Comm... Read more
13d
Bury Free Press
Swales’ determination recognised by two awardsthe world like I’ve been able to.” West Suffolk Sports Awards winners:Allied H
Bury Free Press / Posted 13 days ago
the world like I’ve been able to.” West Suffolk Sports Awards winners:Allied Health Professionals Most Active Workplace - Sanofi, Verse Facilities Management School of the Year - Bury St Edmunds County Upper, Unison Unsung Hero - Ann Williamson,... Read more
13d
asianage
Zika vaccine made from genome shows promise in early human trialvirus, found in at least 60 countries, will keep spreading where mosquitoes tha
asianage / Posted 13 days ago
virus, found in at least 60 countries, will keep spreading where mosquitoes that carry the virus are present. Last month, Sanofi SA ended development efforts on its Zika vaccine, based on an inactivated or killed Zika virus. Takeda Pharmaceutical... Read more
7 related articles
13d
Decclan Chronicle
DNA-based Zika vaccine shows promise in early human trialvirus, found in at least 60 countries, will keep spreading where mosquitoes tha
Decclan Chronicle / Posted 13 days ago
virus, found in at least 60 countries, will keep spreading where mosquitoes that carry the virus are present. Last month, Sanofi SA ended development efforts on its Zika vaccine, based on an inactivated or killed Zika virus. Takeda Pharmaceutical... Read more
7 related articles
13d
Business Wire
ImmunoGen Announces Pricing of Public Offering of Common Stockmarketed product, Kadcyla® and in programs in development by Amgen, Bayer, Biot
Business Wire / Posted 13 days ago
marketed product, Kadcyla® and in programs in development by Amgen, Bayer, Biotest, CytomX, Debiopharm, Lilly, Novartis, Sanofi and Takeda. Kadcyla® is a registered trademark of Genentech, a member of the Roche Group. This press release... Read more
14d
FOX Business
Here's Why Alnylam Pharmaceuticals Rallied 32.7% in SeptemberMarket Intelligence. So what Traders were able to shrug off that bad news with
FOX Business / Posted 14 days ago
Market Intelligence. So what Traders were able to shrug off that bad news within a few days, after Alnylam and its partner Sanofi(NYSE: SNY) released phase 3 clinical data on a drug called patisiran, which is a hopeful treatment for hereditary ATTR... Read more
14d
FOX Business
Here's Why Alnylam Pharmaceuticals Rallied 32.7% in SeptemberMarket Intelligence. So what Traders were able to shrug off that bad news with
FOX Business / Posted 14 days ago
Market Intelligence. So what Traders were able to shrug off that bad news within a few days, after Alnylam and its partner Sanofi(NYSE: SNY) released phase 3 clinical data on a drug called patisiran, which is a hopeful treatment for hereditary ATTR... Read more
14d
FOX News
Zika vaccine shows promise in early human trialvirus, found in at least 60 countries, will keep spreading where mosquitoes tha
FOX News / Posted 14 days ago
virus, found in at least 60 countries, will keep spreading where mosquitoes that carry the virus are present. Last month, Sanofi SA ended development efforts on its Zika vaccine, based on an inactivated or killed Zika virus. Takeda Pharmaceutical... Read more
7 related articles
14d
FOX News
Zika vaccine shows promise in early human trialvirus, found in at least 60 countries, will keep spreading where mosquitoes tha
FOX News / Posted 14 days ago
virus, found in at least 60 countries, will keep spreading where mosquitoes that carry the virus are present. Last month, Sanofi SA ended development efforts on its Zika vaccine, based on an inactivated or killed Zika virus. Takeda Pharmaceutical... Read more
7 related articles
14d
Channel NewsAsia
US court reverses ban on sales of Sanofi, Regeneron drug PraluentREUTERS: A U.S. appeals court has thrown out a ban on sales of Sanofi SA and Re
Channel NewsAsia / Posted 14 days ago
REUTERS: A U.S. appeals court has thrown out a ban on sales of Sanofi SA and Regeneron Pharmaceuticals Inc's cholesterol-lowering drug Praluent, in a closely watched case that could have broad implications for drug development. The ruling on... Read more
14d
Business Wire
North America $1.4 Bn Cancer Vaccines Market, 2022a larger portion of this market. Some of the key participants in the industry
Business Wire / Posted 14 days ago
a larger portion of this market. Some of the key participants in the industry include Prima BioMed, GlaxoSmithKline, Sanofi S.A, Merck, Aduro BioTech, AstraZeneca plc, OXFORD BIOMEDICA etc. Key Topics Covered: 1. Executive Summary 2.... Read more
14d
Newsmax
Zika Vaccine Shows Promise in Early Human Trialvirus, found in at least 60 countries, will keep spreading where mosquitoes tha
Newsmax / Posted 14 days ago
virus, found in at least 60 countries, will keep spreading where mosquitoes that carry the virus are present. Last month, Sanofi SA ended development efforts on its Zika vaccine, based on an inactivated or killed Zika virus. Takeda Pharmaceutical... Read more
7 related articles
14d
Eye Witness News
Zika vaccine shows promise in early human trialvirus, found in at least 60 countries, will keep spreading where mosquitoes tha
Eye Witness News / Posted 14 days ago
virus, found in at least 60 countries, will keep spreading where mosquitoes that carry the virus are present. Last month, Sanofi SA ended development efforts on its Zika vaccine, based on an inactivated or killed Zika virus. Takeda Pharmaceutical... Read more
7 related articles
14d
Fortune
A Zika Vaccine Shows Signs of Success in an Early Human Trialvirus, found in at least 60 countries, will keep spreading where mosquitoes tha
Fortune / Posted 14 days ago
virus, found in at least 60 countries, will keep spreading where mosquitoes that carry the virus are present. Last month, Sanofi SA sanofi-s-a ended development efforts on its Zika vaccine, based on an inactivated or killed Zika virus. Takeda... Read more
7 related articles
15d
Channel NewsAsia
Insurers are slow to approve pricey new cholesterol drugsin the U.S. in 2015 and 2016. The two PCSK9 inhibitors approved in the U.S. ar
Channel NewsAsia / Posted 15 days ago
in the U.S. in 2015 and 2016. The two PCSK9 inhibitors approved in the U.S. are Praluent (alirocumab) marketed by Sanofi/Regeneron and Repatha (evolocumab) marketed by Amgen, the sponsor of the current study. Overall, this class of... Read more
15d
TheBull
Perpetual finding value in global healthcare and consumer staples stockstailwinds over the longer term,” Mr Laurence said. The Fund’s healthcare holdi
TheBull / Posted 15 days ago
tailwinds over the longer term,” Mr Laurence said. The Fund’s healthcare holdings include pharmaceutical company Sanofi Aventis and drug distributor McKesson, stocks expected to benefit from significant market growth as the world’s... Read more
16d
San Fernando Valley Business Journal
MannKind Gains Another 20 Percent on New FDA Labelhave reached 400 a week. This is Afrezza’s best performance since the company e
San Fernando Valley Business Journal / Posted 16 days ago
have reached 400 a week. This is Afrezza’s best performance since the company ended its marketing partnership with Sanofi S.A. last year. Shares of MannKind (MNKD) on Tuesday closed up 48 cents, or nearly 21 percent, at $2.82 on the... Read more
4 related articles
16d
FOX Business
Yield International Stocksto highlight an international stock that they believe is a good choice for inco
FOX Business / Posted 16 days ago
to highlight an international stock that they believe is a good choice for income-focused investors. Here's why they picked Sanofi(NYSE: SNY), Seagate Technology (NASDAQ: STX), and National Grid(NYSE: NGG). A quick turnaround George Budwell... Read more
16d
FOX Business
Yield International Stocksto highlight an international stock that they believe is a good choice for inco
FOX Business / Posted 16 days ago
to highlight an international stock that they believe is a good choice for income-focused investors. Here's why they picked Sanofi(NYSE: SNY), Seagate Technology (NASDAQ: STX), and National Grid(NYSE: NGG). A quick turnaround George Budwell... Read more
16d
Newsmax
World's First Universal Flu Vaccine to be Testedcompany to take this into final Phase III tests," he said. Leading manufacture
Newsmax / Posted 16 days ago
company to take this into final Phase III tests," he said. Leading manufacturers of seasonal flu vaccines include Sanofi, GlaxoSmithKline and CSL's Seqirus, which includes the old Novartis flu vaccine business. (Reporting by Ben... Read more
53 related articles
16d
Eye Witness News
Oxford team to test universal flu vaccine in world firstwould look for a better-capitalised company to take this into final Phase III t
Eye Witness News / Posted 16 days ago
would look for a better-capitalised company to take this into final Phase III tests,” he said. Leading manufacturers of seasonal flu vaccines include Sanofi, GlaxoSmithKline and CSL’s Seqirus, which includes the old Novartis flu vaccine bu... Read more
53 related articles
16d
Business Wire
X-Chem Further Expands Collaboration with Bayer to Discover Novel Medicinesto date, and has established partnerships with AbbVie, Alexion, Astellas, Astra
Business Wire / Posted 16 days ago
to date, and has established partnerships with AbbVie, Alexion, Astellas, AstraZeneca, Bayer, Janssen, Ono, Pfizer, Sanofi, Taiho, Vertex, and many other leading pharmaceutical and biotechnology companies. For further information on X-Chem,... Read more
16d
Sky News Australia
UK team to test universal flu vaccineis the first time a universal flu vaccine has progressed beyond Phase I clinica
Sky News Australia / Posted 16 days ago
is the first time a universal flu vaccine has progressed beyond Phase I clinical testing. Leading manufacturers of seasonal flu vaccines include Sanofi, GlaxoSmithKline and CSL's Seqirus, which includes the old Novartis flu vaccine business. Reut... Read more
53 related articles
16d
Herald Sun
UK team to test universal flu vaccineis the first time a universal flu vaccine has progressed beyond Phase I clinica
Herald Sun / Posted 16 days ago
is the first time a universal flu vaccine has progressed beyond Phase I clinical testing. Leading manufacturers of seasonal flu vaccines include Sanofi, GlaxoSmithKline and CSL's Seqirus, which includes the old Novartis flu vacci... Read more
53 related articles
More

In this news